The $65 Million Perk for CEOs: Personal Use of the Corporate Jet Has Soared

[ad_1] One of the flashiest executive perks has roared back since the onset of the pandemic: free personal travel on the company jet. Companies in the S&P 500 spent $65…

Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion

[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…

Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B

[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…

Elon Musk Has Used Illegal Drugs, Worrying Leaders at Tesla and SpaceX

[ad_1] Some executives and board members fear the billionaire’s use of drugs—including LSD, cocaine, ecstasy, mushrooms and ketamine—could harm his companies. [ad_2] Source link

Psychedelics Are Going Mainstream. Investing in Them Hasn’t.

[ad_1] Psychedelics spent a half-century in political and medical purgatory. Now they’re starting to go mainstream. Respected academic institutes and billionaires are funding research into their therapeutic benefits, and the…

You Can Now Get Weight-Loss Drugs Right From Eli Lilly

[ad_1] Eli Lilly started a new online service offering telehealth prescriptions and direct home delivery of its new anti-obesity drug Zepbound, an unusual move into the drug supply chain by…

The Future Is Bright if You Know Where to Look

[ad_1] A burst of advances in artificial intelligence, medicine and elsewhere promise a better life down the road. [ad_2] Source link

Essay | For Happiness in the New Year, Stop Overdoing Everything

[ad_1] Overachieving and overthinking are ways we try to feel more secure, but they can seriously hurt our mental and physical health [ad_2] Source link

Opinion | The Employee Retention Tax Credit Is the Biggest Covid Scam

[ad_1] It’s hard to feel sorry for the Internal Revenue Service, but cleaning up for Congress is never fun. The Covid employee retention tax credit is turning into a classic…

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

[ad_1] In pharma, you can take a larger slice of the healthcare pie than your peers, but you are still constrained by the size of the pie. No matter how…